Recent developments in the use of antiplatelet agents to prevent cardiovascular events

Author： Lischke Stefan   Schneider David J  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.7, Iss.3, 2011-05, pp. : 403-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet agents in cardiovascular disease

By Lopes Renato  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 306-309

Springer Publishing Company

Access to resources Recommend Favorite

Current Oral Antiplatelet Agents to Prevent Atherothrombosis

By  

Cerebrovascular Diseases, Vol. 11, Iss. 2, 2001-04 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Statin Use in Aortic Aneurismal Disease to Prevent Progression and Cardiovascular Events: Review of Experimental and Clinical Data

By  

Current Vascular Pharmacology, Vol. 11, Iss. 3, 2013-01 ,pp. : 299-304

Bentham Science Publishers

Access to resources Recommend Favorite

Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 55-60

Bentham Science Publishers

Access to resources Recommend Favorite

Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy

By Christie Douglas   Kottke-Marchant Kandice   Gorman Robert  

Platelets, Vol. 19, Iss. 2, 2007-07 ,pp. : 104-110

Informa Healthcare

Access to resources Recommend Favorite